CXCR3 as a molecular target in breast cancer metastasis

inhibition of tumor cell migration and promotion of host anti-tumor immunity

Guiquan Zhu, H Hannah Yan, Yanli Pang, Jiang Jian, Bhagelu R Achyut, Xinhua Liang, Jonathan M Weiss, Robert H Wiltrout, M Christine Hollander, Li Yang

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Chemokines and chemokine receptors have critical roles in cancer metastasis and have emerged as one of the targeting options in cancer therapy. However, the treatment efficacy on both tumor and host compartments needs to be carefully evaluated. Here we report that targeting CXCR3 decreased tumor cell migration and at the same time improved host anti-tumor immunity. We observed an increased expression of CXCR3 in metastatic tumor cells compared to those from non-metastatic tumor cells. Knockdown (KD) of CXCR3 in metastatic tumor cells suppressed tumor cell migration and metastasis. Importantly, CXCR3 expression in clinical breast cancer samples correlated with progression and metastasis. For the host compartment, deletion of CXCR3 in all host cells in 4T1 mammary tumor model significantly decreased metastasis. The underlying mechanisms involve a decreased expression of IL-4, IL-10, iNOs, and Arg-1 in myeloid cells and an increased T cell response. IFN-γ neutralization diminished the metastasis inhibition in the CXCR3 knockout (KO) mice bearing 4T1 tumors, suggesting a critical role of host CXCR3 in immune suppression. Consistently, targeting CXCR3 using a small molecular inhibitor (AMG487) significantly suppressed metastasis and improved host anti-tumor immunity. Our findings demonstrate that targeting CXCR3 is effective in both tumor and host compartments, and suggest that CXCR3 inhibition is likely to avoid adverse effects on host cells.

Original languageEnglish (US)
Pages (from-to)43408-19
Number of pages12
JournalOncotarget
Volume6
Issue number41
DOIs
StatePublished - Dec 22 2015
Externally publishedYes

Fingerprint

Cell Migration Inhibition
Immunity
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Cell Movement
Chemokine Receptors
Myeloid Cells
Chemokines
Knockout Mice
Interleukin-4
Interleukin-10

Keywords

  • Journal Article
  • Research Support, N.I.H., Intramural

Cite this

CXCR3 as a molecular target in breast cancer metastasis : inhibition of tumor cell migration and promotion of host anti-tumor immunity. / Zhu, Guiquan; Yan, H Hannah; Pang, Yanli; Jian, Jiang; Achyut, Bhagelu R; Liang, Xinhua; Weiss, Jonathan M; Wiltrout, Robert H; Hollander, M Christine; Yang, Li.

In: Oncotarget, Vol. 6, No. 41, 22.12.2015, p. 43408-19.

Research output: Contribution to journalArticle

Zhu, G, Yan, HH, Pang, Y, Jian, J, Achyut, BR, Liang, X, Weiss, JM, Wiltrout, RH, Hollander, MC & Yang, L 2015, 'CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity', Oncotarget, vol. 6, no. 41, pp. 43408-19. https://doi.org/10.18632/oncotarget.6125
Zhu, Guiquan ; Yan, H Hannah ; Pang, Yanli ; Jian, Jiang ; Achyut, Bhagelu R ; Liang, Xinhua ; Weiss, Jonathan M ; Wiltrout, Robert H ; Hollander, M Christine ; Yang, Li. / CXCR3 as a molecular target in breast cancer metastasis : inhibition of tumor cell migration and promotion of host anti-tumor immunity. In: Oncotarget. 2015 ; Vol. 6, No. 41. pp. 43408-19.
@article{83485d52b2f44cb68b2ed28ad057275a,
title = "CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity",
abstract = "Chemokines and chemokine receptors have critical roles in cancer metastasis and have emerged as one of the targeting options in cancer therapy. However, the treatment efficacy on both tumor and host compartments needs to be carefully evaluated. Here we report that targeting CXCR3 decreased tumor cell migration and at the same time improved host anti-tumor immunity. We observed an increased expression of CXCR3 in metastatic tumor cells compared to those from non-metastatic tumor cells. Knockdown (KD) of CXCR3 in metastatic tumor cells suppressed tumor cell migration and metastasis. Importantly, CXCR3 expression in clinical breast cancer samples correlated with progression and metastasis. For the host compartment, deletion of CXCR3 in all host cells in 4T1 mammary tumor model significantly decreased metastasis. The underlying mechanisms involve a decreased expression of IL-4, IL-10, iNOs, and Arg-1 in myeloid cells and an increased T cell response. IFN-γ neutralization diminished the metastasis inhibition in the CXCR3 knockout (KO) mice bearing 4T1 tumors, suggesting a critical role of host CXCR3 in immune suppression. Consistently, targeting CXCR3 using a small molecular inhibitor (AMG487) significantly suppressed metastasis and improved host anti-tumor immunity. Our findings demonstrate that targeting CXCR3 is effective in both tumor and host compartments, and suggest that CXCR3 inhibition is likely to avoid adverse effects on host cells.",
keywords = "Journal Article, Research Support, N.I.H., Intramural",
author = "Guiquan Zhu and Yan, {H Hannah} and Yanli Pang and Jiang Jian and Achyut, {Bhagelu R} and Xinhua Liang and Weiss, {Jonathan M} and Wiltrout, {Robert H} and Hollander, {M Christine} and Li Yang",
year = "2015",
month = "12",
day = "22",
doi = "10.18632/oncotarget.6125",
language = "English (US)",
volume = "6",
pages = "43408--19",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "41",

}

TY - JOUR

T1 - CXCR3 as a molecular target in breast cancer metastasis

T2 - inhibition of tumor cell migration and promotion of host anti-tumor immunity

AU - Zhu, Guiquan

AU - Yan, H Hannah

AU - Pang, Yanli

AU - Jian, Jiang

AU - Achyut, Bhagelu R

AU - Liang, Xinhua

AU - Weiss, Jonathan M

AU - Wiltrout, Robert H

AU - Hollander, M Christine

AU - Yang, Li

PY - 2015/12/22

Y1 - 2015/12/22

N2 - Chemokines and chemokine receptors have critical roles in cancer metastasis and have emerged as one of the targeting options in cancer therapy. However, the treatment efficacy on both tumor and host compartments needs to be carefully evaluated. Here we report that targeting CXCR3 decreased tumor cell migration and at the same time improved host anti-tumor immunity. We observed an increased expression of CXCR3 in metastatic tumor cells compared to those from non-metastatic tumor cells. Knockdown (KD) of CXCR3 in metastatic tumor cells suppressed tumor cell migration and metastasis. Importantly, CXCR3 expression in clinical breast cancer samples correlated with progression and metastasis. For the host compartment, deletion of CXCR3 in all host cells in 4T1 mammary tumor model significantly decreased metastasis. The underlying mechanisms involve a decreased expression of IL-4, IL-10, iNOs, and Arg-1 in myeloid cells and an increased T cell response. IFN-γ neutralization diminished the metastasis inhibition in the CXCR3 knockout (KO) mice bearing 4T1 tumors, suggesting a critical role of host CXCR3 in immune suppression. Consistently, targeting CXCR3 using a small molecular inhibitor (AMG487) significantly suppressed metastasis and improved host anti-tumor immunity. Our findings demonstrate that targeting CXCR3 is effective in both tumor and host compartments, and suggest that CXCR3 inhibition is likely to avoid adverse effects on host cells.

AB - Chemokines and chemokine receptors have critical roles in cancer metastasis and have emerged as one of the targeting options in cancer therapy. However, the treatment efficacy on both tumor and host compartments needs to be carefully evaluated. Here we report that targeting CXCR3 decreased tumor cell migration and at the same time improved host anti-tumor immunity. We observed an increased expression of CXCR3 in metastatic tumor cells compared to those from non-metastatic tumor cells. Knockdown (KD) of CXCR3 in metastatic tumor cells suppressed tumor cell migration and metastasis. Importantly, CXCR3 expression in clinical breast cancer samples correlated with progression and metastasis. For the host compartment, deletion of CXCR3 in all host cells in 4T1 mammary tumor model significantly decreased metastasis. The underlying mechanisms involve a decreased expression of IL-4, IL-10, iNOs, and Arg-1 in myeloid cells and an increased T cell response. IFN-γ neutralization diminished the metastasis inhibition in the CXCR3 knockout (KO) mice bearing 4T1 tumors, suggesting a critical role of host CXCR3 in immune suppression. Consistently, targeting CXCR3 using a small molecular inhibitor (AMG487) significantly suppressed metastasis and improved host anti-tumor immunity. Our findings demonstrate that targeting CXCR3 is effective in both tumor and host compartments, and suggest that CXCR3 inhibition is likely to avoid adverse effects on host cells.

KW - Journal Article

KW - Research Support, N.I.H., Intramural

U2 - 10.18632/oncotarget.6125

DO - 10.18632/oncotarget.6125

M3 - Article

VL - 6

SP - 43408

EP - 43419

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 41

ER -